These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15901610

  • 1. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias.
    Kiri VA, Pride NB, Soriano JB, Vestbo J.
    Am J Respir Crit Care Med; 2005 Aug 15; 172(4):460-4. PubMed ID: 15901610
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies.
    Suissa S.
    Am J Respir Crit Care Med; 2003 Jul 01; 168(1):49-53. PubMed ID: 12663327
    [Abstract] [Full Text] [Related]

  • 3. Immeasurable time bias in observational studies of drug effects on mortality.
    Suissa S.
    Am J Epidemiol; 2008 Aug 01; 168(3):329-35. PubMed ID: 18515793
    [Abstract] [Full Text] [Related]

  • 4. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
    Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, Au DH.
    Am J Respir Crit Care Med; 2003 Dec 15; 168(12):1488-94. PubMed ID: 14525798
    [Abstract] [Full Text] [Related]

  • 5. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P, Gonzalez AV, Brassard P, Suissa S.
    Am J Respir Crit Care Med; 2007 Jul 15; 176(2):162-6. PubMed ID: 17400730
    [Abstract] [Full Text] [Related]

  • 6. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun 15; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 7. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 15; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 8. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M, Biddle AK, Stearns SC.
    Clin Ther; 2008 Apr 15; 30 Spec No():1003-16. PubMed ID: 18640475
    [Abstract] [Full Text] [Related]

  • 9. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 10. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time.
    Suissa S.
    Eur Respir J; 2004 Mar 10; 23(3):391-5. PubMed ID: 15065827
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA, Fabbri LM, Davis KJ, Soriano JB.
    Respir Med; 2009 Jan 10; 103(1):85-90. PubMed ID: 18793832
    [Abstract] [Full Text] [Related]

  • 12. Immortal time bias in pharmaco-epidemiology.
    Suissa S.
    Am J Epidemiol; 2008 Feb 15; 167(4):492-9. PubMed ID: 18056625
    [Abstract] [Full Text] [Related]

  • 13. Immortal time bias in observational studies of drug effects.
    Suissa S.
    Pharmacoepidemiol Drug Saf; 2007 Mar 15; 16(3):241-9. PubMed ID: 17252614
    [Abstract] [Full Text] [Related]

  • 14. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA, Bettoncelli G, Testi R, Viegi G.
    Respir Med; 2005 Sep 15; 99(9):1115-24. PubMed ID: 15921904
    [Abstract] [Full Text] [Related]

  • 15. Inhaled glucocorticoids in COPD: immortal time bias.
    Pride NB, Vestbo J, Soriano JB, Kiri VA.
    Am J Respir Crit Care Med; 2003 Jul 01; 168(1):127. PubMed ID: 12870509
    [No Abstract] [Full Text] [Related]

  • 16. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].
    Bridevaux PO, Leuenberger P.
    Rev Med Suisse; 2005 Nov 16; 1(41):2673-4, 2677-9. PubMed ID: 16355882
    [Abstract] [Full Text] [Related]

  • 17. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 16; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 18. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    Vollmer WM, Peters D, Crane B, Kelleher C, Buist AS.
    COPD; 2007 Jun 16; 4(2):135-42. PubMed ID: 17530507
    [Abstract] [Full Text] [Related]

  • 19. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.
    Lee TA, Weiss KB.
    Am J Respir Crit Care Med; 2004 Apr 01; 169(7):855-9. PubMed ID: 14711795
    [Abstract] [Full Text] [Related]

  • 20. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb 01; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.